Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Liu Y.-N.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 1 到 20 筆資料,總共 28 筆
下一頁 >
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2019
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU
; Chang T.-H.; TZU-HSIU TSAI
; Gow C.-H.; YIH-LEONG CHANG
; JIN-YUAN SHIH
International Journal of Cancer
34
34
2016
Akt activation correlates with snail expression and potentially determines the recurrence of prostate cancer in patients at stage T2 after a radical prostatectomy
Chen W.-Y.; KUO-TAI HUA
; Lee W.-J.; Lin Y.-W.; Liu Y.-N.; Chen C.-L.; Wen Y.-C.; Chien M.-H.
International Journal of Molecular Sciences
3
3
2009
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents
Yang X.; Shi Q.; Liu Y.-N.; Zhao G.; Bastow K.F.; Lin J.-C.; Yang S.-C.; PAN-CHYR YANG
; Lee K.-H.
Journal of Medicinal Chemistry
43
41
2016
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
SHANG-GIN WU
; Liu Y.-N.; CHONG-JEN YU
; PAN-CHYR YANG
; JIN-YUAN SHIH
JAMA Oncology
20
16
2014
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
YEN-FU CHEN
; MIN-SHU HSIEH
; SHANG-GIN WU
; YIH-LEONG CHANG
; JIN-YUAN SHIH
; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI
; CHONG-JEN YU
; CHIH-HSIN YANG
; PAN-CHYR YANG
Journal of Thoracic Oncology
68
64
2021
Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma
Gow C.-H.; MIN-SHU HSIEH
; Liu Y.-N.; Lee Y.-H.; JIN-YUAN SHIH
Cancers
10
8
2020
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
YEN-TING LIN
; TZU-HSIU TSAI
; SHANG-GIN WU
; Liu Y.-N.; CHONG-JEN YU
; JIN-YUAN SHIH
Lung Cancer
17
17
2015
Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib
Gow C.-H.; WEI-YU LIAO
; Liu Y.-N.; JIN-YUAN SHIH
Journal of Thoracic Oncology
14
14
2018
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
SHANG-GIN WU
; Liu Y.-N.; CHONG-JEN YU
; CHIH-HSIN YANG
; JIN-YUAN SHIH
Genes Chromosomes and Cancer
10
10
2017
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer
YEN-TING LIN
; Liu Y.-N.; SHANG-GIN WU
; CHIH-HSIN YANG
; JIN-YUAN SHIH
Clinical Lung Cancer
32
26
2009
Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1α accumulation in RAW264.7
Liu Y.-N.; Pan S.-L.; Liao C.-H.; Huang D.-Y.; JIH-HWA GUH
; Peng C.-Y.; Chang Y.-L.; Teng C.-M.
Shock
67
58
2019
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
SHANG-GIN WU
; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU
; YIH-LEONG CHANG
; CHONG-JEN YU
; JIN-YUAN SHIH
Cancers
15
12
2015
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
Liu Y.-N.; Chang T.-H.; Tsai M.-F.; SHANG-GIN WU
; TZU-HSIU TSAI
; Chen H.-Y.; SUNG-LIANG YU
; CHIH-HSIN YANG
; JIN-YUAN SHIH
Oncotarget
57
56
2019
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
YEN-TING LIN
; Liu Y.-N.; JIN-YUAN SHIH
Frontiers in Oncology
10
8
2004
The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury
Peng C.-Y.; Pan S.-L.; JIH-HWA GUH
; Liu Y.-N.; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Thrombosis and Haemostasis
21
21
2016
Measuring propionyl-CoA carboxylase activity in phytohemagglutinin stimulated lymphocytes using high performance liquid chromatography
Liu Y.-N.; Liu T.-T.; Fan Y.-L.; Niu D.-M.; YIN-HSIU CHIEN
; Chou Y.-Y.; NI-CHUNG LEE
; Hsiao K.-J.; Chiu Y.-H.
Clinica Chimica Acta
4
4
2016
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
SHANG-GIN WU
; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG
; CHONG-JEN YU
; PAN-CHYR YANG
; CHIH-HSIN YANG
; Wen Y.-F.; JIN-YUAN SHIH
Oncotarget
207
191
2019
MicroRNA in lung cancer metastasis
SHANG-GIN WU
; Chang T.-H.; Liu Y.-N.; JIN-YUAN SHIH
Cancers
53
47
2010
Moscatilin repressed lipopolysaccharide-induced hif-1α accumulation and NF-κB activation in murine raw264.7 cells
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH
; Chen C.-C.; Shen C.-C.; Teng C.-M.
Shock
28
26
2010
Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo
Tsai A.-C.; Pan S.-L.; Liao C.-H.; JIH-HWA GUH
; Wang S.-W.; Sun H.-L.; Liu Y.-N.; Chen C.-C.; Shen C.-C.; Chang Y.-L.; Teng C.-M.
Cancer Letters
59
48